Gleevec News
Most Popular Gleevec Story
Novartis, Roche blockbusters shine at ASCO
While experimental therapies grab a major chunk of the attention at the annual ASCO meeting, existing drugs have their share of new data to crow about. Here's a roundup of the biggest news coming out Read more...
Latest Headlines
- September 21, 2011
- June 6, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
